|Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine|
LR Baden, HM El Sahly, B Essink, K Kotloff, S Frey, R Novak, D Diemert, ...
New England Journal of Medicine 384 (5), 403-416, 2021
|Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study|
KL Kotloff, JP Nataro, WC Blackwelder, D Nasrin, TH Farag, ...
The Lancet 382 (9888), 209-222, 2013
|Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.|
KL Kotloff, JP Winickoff, B Ivanoff, JD Clemens, DL Swerdlow, ...
Bulletin of the World Health Organization 77 (8), 651, 1999
|Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015|
C Troeger, M Forouzanfar, PC Rao, I Khalil, A Brown, RC Reiner Jr, ...
The Lancet Infectious Diseases 17 (9), 909-948, 2017
|The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children|
RB Belshe, PM Mendelman, J Treanor, J King, WC Gruber, P Piedra, ...
New England Journal of Medicine 338 (20), 1405-1412, 1998
|Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review …|
T Shi, DA McAllister, KL O'Brien, EAF Simoes, SA Madhi, BD Gessner, ...
The Lancet 390 (10098), 946-958, 2017
|A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium|
W Checkley, AC White Jr, D Jaganath, MJ Arrowood, RM Chalmers, ...
The Lancet Infectious Diseases 15 (1), 85-94, 2015
|A Multicentre Study of Shigella Diarrhoea in Six Asian Countries: Disease Burden, Clinical Manifestations, and Microbiology|
L Von Seidlein, DR Kim, M Ali, H Lee, XY Wang, VD Thiem, DG Canh, ...
PLoS medicine 3 (9), e353, 2006
|Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine|
RB Belshe, WC Gruber, PM Mendelman, I Cho, K Reisinger, SL Block, ...
The Journal of pediatrics 136 (2), 168-175, 2000
|Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study|
J Liu, JA Platts-Mills, J Juma, F Kabir, J Nkeze, C Okoi, DJ Operario, ...
The Lancet 388 (10051), 1291-1301, 2016
|Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine|
RB Belshe, WC Gruber, PM Mendelman, HB Mehta, K Mahmood, ...
The Journal of infectious diseases 181 (3), 1133-1137, 2000
|2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea|
AL Shane, RK Mody, JA Crump, PI Tarr, TS Steiner, K Kotloff, JM Langley, ...
Clinical Infectious Diseases 65 (12), e45-e80, 2017
|Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori–infected adults|
P Michetti, C Kreiss, KL Kotloff, N Porta, JL Blanco, D Bachmann, ...
Gastroenterology 116 (4), 804-812, 1999
|Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road|
MM Levine, KL Kotloff, EM Barry, MF Pasetti, MB Sztein
Nature Reviews Microbiology 5 (7), 540-553, 2007
|Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with …|
JJ Treanor, K Kotloff, RF Betts, R Belshe, F Newman, D Iacuzio, J Wittes, ...
Vaccine 18 (9-10), 899-906, 1999
|The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study|
KL Kotloff, WC Blackwelder, D Nasrin, JP Nataro, TH Farag, A van Eijk, ...
Clinical infectious diseases 55 (suppl_4), S232-S245, 2012
|Shigella Isolates From the Global Enteric Multicenter Study Inform Vaccine Development|
S Livio, NA Strockbine, S Panchalingam, SM Tennant, EM Barry, ...
Clinical Infectious Diseases 59 (7), 933-941, 2014
KL Kotloff, MS Riddle, JA Platts-Mills, P Pavlinac, AKM Zaidi
The Lancet 391 (10122), 801-812, 2018
|Measurement of fecal lactoferrin as a marker of fecal leukocytes|
RL Guerrant, V Araujo, E Soares, K Kotloff, AA Lima, WH Cooper, AG Lee
Journal of clinical microbiology 30 (5), 1238-1242, 1992
|Safety and Immunogenicity of Oral Inactivated Whole-CellHelicobacter pylori Vaccine with Adjuvant among Volunteers with or without Subclinical Infection|
KL Kotloff, MB Sztein, SS Wasserman, GA Losonsky, SC DiLorenzo, ...
Infection and immunity 69 (6), 3581-3590, 2001